{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:33:11Z","timestamp":1787002391170,"version":"build-2736575974"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>Intraoperative blood salvage (IBS) and autotransfusion have been widely implemented to minimize allogenic blood transfusion in major surgery. Despite published literature, controversy exists around its use in liver transplantation (LT) for patients with hepatocellular carcinoma (HCC) due to concern for oncological recurrence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>We retrospectively studied adults with HCC who underwent deceased donor LT at a single LT center in Australia (August 2007\u2013July 2020), comparing those who received IBS and autotransfusion with those who did not. Leukodepletion filters were not used. The primary outcome was time to HCC recurrence. The secondary outcomes were HCC recurrence-free survival and overall survival post-LT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      A total of 245 patients having concurrent LT and HCC were analyzed. Of these, 167 received IBS and 78 did not. HCC recurrence occurred in 22\/245 (9.0%) after a median of 20 months (IQR 13.5\u201324.5). For the primary outcome, IBS and autotransfusion was not associated with a decrease in time to HCC recurrence on unadjusted analysis (hazard ratio [HR] 0.80, 95% confidence interval [CI] 0.34\u20131.92;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .62). Independent predictors of time to HCC recurrence were: hepatitis C (adjusted HR [aHR] 3.57, 95% CI, 1.03\u201312.4,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .04), number of HCCs (aHR 1.17 per lesion increase, 95% CI, 1.06\u20131.30,\n                      <jats:italic toggle=\"yes\">P &lt;<\/jats:italic>\n                      .01), higher alpha-fetal protein levels (aHR 1.002 per kIU\/L increase, 95% CI, 1.0003\u20131.003,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .01), and microvascular invasion (aHR 3.27, 95% CI, 1.26\u20138.50,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .01). After adjusting for these confounders, there remained no relationship between IBS and autotransfusion and time to HCC recurrence (aHR 0.57, 95% CI, 0.23\u20131.44,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .24). For the secondary outcomes, IBS and autotransfusion was not a predictor of HCC recurrence-free survival (aHR 0.75, 95% CI, 0.39\u20131.42,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .38) or overall survival (aHR 0.68, 95% CI, 0.35\u20131.33,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .26) on multivariable analysis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>In this single-center study, IBS and autotransfusion during LT in patients with concurrent HCC was not associated with an increased risk of recurrence. No unexpected risk factors for HCC recurrence after LT were identified. This study provides further evidence to confirm the safety of IBS in LT for HCC without the use of leukodepletion filters.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1213\/ane.0000000000007998","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T16:00:10Z","timestamp":1774022410000},"page":"588-595","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Hepatocellular Cancer Recurrence After Liver Transplantation With and Without the Use of Intraoperative Blood Salvage and Autotransfusion: A Retrospective Study"],"prefix":"10.1213","volume":"143","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-8273-5114","authenticated-orcid":false,"given":"Elise V.","family":"Butler","sequence":"first","affiliation":[{"name":"From theDepartment of Anaesthesia, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia"},{"name":"Australian National Liver Transplant Unit, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline L.","family":"Robson","sequence":"additional","affiliation":[{"name":"From theDepartment of Anaesthesia, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia"},{"name":"Australian National Liver Transplant Unit, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Ponsonby","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, St Vincent\u2019s Hospital, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avik","family":"Majumdar","sequence":"additional","affiliation":[{"name":"Victorian Liver Transplant Unit, Austin Health, Heidelberg, Victoria, Australia"},{"name":"Melbourne Medical School, The University of Melbourne, Melbourne, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone I.","family":"Strasser","sequence":"additional","affiliation":[{"name":"Australian National Liver Transplant Unit, Sydney, New South Wales, Australia"},{"name":"AW Morrow Gastroenterology and Liver Centre, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia"},{"name":"Central Clinical School of Medicine, The University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanchia","family":"Smith","sequence":"additional","affiliation":[{"name":"From theDepartment of Anaesthesia, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Liu","sequence":"additional","affiliation":[{"name":"Australian National Liver Transplant Unit, Sydney, New South Wales, Australia"},{"name":"AW Morrow Gastroenterology and Liver Centre, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia"},{"name":"Central Clinical School of Medicine, The University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D. J.","family":"Watts","sequence":"additional","affiliation":[{"name":"From theDepartment of Anaesthesia, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia"},{"name":"Australian National Liver Transplant Unit, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,3,20]]},"reference":[{"key":"R1-20260817","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1002\/lt.25859","article-title":"Differential impact of extended criteria donors after brain death or circulatory death in adult liver transplantation.","volume":"26","author":"Pandya","year":"2020","journal-title":"Liver Transpl"},{"key":"R2-20260817","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1182\/blood-2008-10-167643","article-title":"Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention.","volume":"113","author":"Vamvakas","year":"2009","journal-title":"Blood"},{"key":"R3-20260817","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.athoracsur.2013.07.020","article-title":"Transfusion of 1 and 2 units of red blood cells is associated with increased morbidity and mortality.","volume":"97","author":"Paone","year":"2014","journal-title":"Ann Thorac Surg"},{"key":"R4-20260817","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/01.SA.0000407029.96458.69","article-title":"Association between intraoperative blood transfusion and mortality and morbidity in patients undergoing noncardiac surgery.","volume":"55","author":"Glance","year":"2011","journal-title":"Survey Anesthesiol"},{"key":"R5-20260817","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.bja.2023.08.032","article-title":"Outcomes following perioperative red blood cell transfusion in patients undergoing elective major abdominal surgery: a systematic review and meta-analysis.","volume":"131","author":"Morris","year":"2023","journal-title":"Br J Anaesth"},{"key":"R6-20260817","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/SLA.0000000000002062","article-title":"Perioperative Fresh Red Blood Cell Transfusion May Negatively Affect Recipient Survival After Liver Transplantation.","volume":"267","author":"Han","year":"2018","journal-title":"Ann Surg"},{"key":"R7-20260817","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1093\/bja\/aet068","article-title":"Inflammatory response, immunosuppression, and cancer recurrence after perioperative blood transfusions.","volume":"110","author":"Cata","year":"2013","journal-title":"Br J Anaesth"},{"key":"R8-20260817","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/anae.14862","article-title":"The association of allogeneic blood transfusion and the recurrence of hepatic cancer after surgical resection.","volume":"75","author":"Tai","year":"2020","journal-title":"Anaesthesia"},{"key":"R9-20260817","doi-asserted-by":"crossref","first-page":"e22568","DOI":"10.1097\/MD.0000000000022568","article-title":"Impact of intraoperative allogenic and autologous transfusion on immune function and prognosis in patients with hepatocellular carcinoma.","volume":"99","author":"Gong","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"R10-20260817","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/01.tp.0000199318.17013.c5","article-title":"A prospective study investigating the cost effectiveness of intraoperative blood salvage during liver transplantation.","volume":"81","author":"Phillips","year":"2006","journal-title":"Transplantation"},{"key":"R11-20260817","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/bja\/aeq244","article-title":"Cell salvage as part of a blood conservation strategy in anaesthesia.","volume":"105","author":"Ashworth","year":"2010","journal-title":"Br J Anaesth"},{"key":"R12-20260817","first-page":"139","article-title":"Intra-operative cell salvage: a fresh look at the indications and contraindications.","volume":"9","author":"Esper","year":"2011","journal-title":"Blood Transfus"},{"key":"R13-20260817","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.3748\/wjg.v19.i22.3371","article-title":"Controversy over the use of intraoperative blood salvage autotransfusion during liver transplantation for hepatocellular carcinoma patients.","volume":"19","author":"Zhai","year":"2013","journal-title":"World J Gastroenterol"},{"key":"R14-20260817","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1111\/j.1537-2995.2009.02256.x","article-title":"Blood salvage use in gynecologic oncology.","volume":"49","author":"Nagarsheth","year":"2009","journal-title":"Transfusion"},{"key":"R15-20260817","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1097\/TP.0b013e3181671f2e","article-title":"Intraoperative blood salvage during liver transplantation in patients with hepatocellular carcinoma; efficiency of leukocyte depletion filters in the removal of tumor cells.","volume":"85","author":"Liang","year":"2008","journal-title":"Transplantation"},{"key":"R16-20260817","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/tme.12453","article-title":"Metastatic efficiency of tumour cells can be impaired by intraoperative cell salvage process: truth or conjecture?","volume":"27","author":"Kumar","year":"2017","journal-title":"Transf Med"},{"key":"R17-20260817","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/lt.20346","article-title":"Can a leukocyte depletion filter (LDF) reduce the risk of reintroduction of hepatocellular carcinoma cells?","volume":"11","author":"Gwak","year":"2005","journal-title":"Liver Transplant"},{"key":"R18-20260817","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1111\/j.1537-2995.2011.03555.x","article-title":"Blood salvage and cancer surgery: a meta-analysis of available studies.","volume":"52","author":"Waters","year":"2012","journal-title":"Transfusion"},{"key":"R19-20260817","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.3748\/wjg.v17.i32.3709","article-title":"Advantage of autologous blood transfusion in surgery for hepatocellular carcinoma.","volume":"17","author":"Tomimaru","year":"2011","journal-title":"World J Gastroenterol"},{"key":"R20-20260817","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1464-410X.2005.05621.x","article-title":"Analysis of peripheral blood for prostate cells after autologous transfusion given during radical prostatectomy.","volume":"96","author":"Stoffel","year":"2005","journal-title":"Bju Int"},{"key":"R21-20260817","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1111\/j.1537-2995.2012.03682.x","article-title":"Intraoperative cell salvage in radical prostatectomy does not appear to increase long-term biochemical recurrence, metastases, or mortality.","volume":"52","author":"Raval","year":"2012","journal-title":"Transfusion"},{"key":"R22-20260817","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.urology.2004.10.062","article-title":"Intraoperative cell salvage during radical prostatectomy is not associated with greater biochemical recurrence rate.","volume":"65","author":"Nieder","year":"2005","journal-title":"Urology"},{"key":"R23-20260817","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1046\/j.1464-410X.2003.04129.x","article-title":"The use of cell salvage during radical retropubic prostatectomy: does it influence cancer recurrence?","volume":"91","author":"Davis","year":"2003","journal-title":"Bju Int"},{"key":"R24-20260817","doi-asserted-by":"crossref","first-page":"e16040","DOI":"10.1097\/MD.0000000000016040","article-title":"Survival analysis of intraoperative blood salvage for patients with malignancy disease: a PRISMA-compliant systematic review and meta-analysis.","volume":"98","author":"Wu","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"R25-20260817","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000524538","article-title":"Safety of intraoperative cell salvage in cancer surgery: an updated meta-analysis of the current literature.","volume":"49","author":"Frietsch","year":"2022","journal-title":"Transfus Med Hemother"},{"key":"R26-20260817","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/j.transproceed.2021.03.025","article-title":"Cell salvage during liver transplantation for hepatocellular carcinoma: a retrospective analysis of tumor recurrence following irradiation of the salvaged blood.","volume":"53","author":"Weller","year":"2021","journal-title":"Transplant Proc"},{"key":"R27-20260817","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00423-020-01997-7","article-title":"Impact of intraoperative blood salvage and autologous transfusion during liver transplantation for hepatocellular carcinoma.","volume":"406","author":"Pinto","year":"2021","journal-title":"Langenbecks Arch Surg"},{"key":"R28-20260817","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1111\/tri.14150","article-title":"Safety of intra-operative blood salvage during liver transplantation in patients with hepatocellular carcinoma, a propensity score-matched survival analysis.","volume":"34","author":"Nutu","year":"2021","journal-title":"Transpl Int"},{"key":"R29-20260817","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/j.1432-2277.2005.00207.x","article-title":"Blood salvage autotransfusion during transplantation for hepatocarcinoma: does it increase the risk of neoplastic recurrence?.","volume":"18","author":"Muscari","year":"2005","journal-title":"Transplant Inter"},{"key":"R30-20260817","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/tri.12001","article-title":"Long-term results for living donor liver transplant recipients with hepatocellular carcinoma using intraoperative blood salvage with leukocyte depletion filter.","volume":"26","author":"Kim","year":"2013","journal-title":"Transplant Inter"},{"key":"R31-20260817","doi-asserted-by":"crossref","first-page":"6816","DOI":"10.1245\/s10434-021-09863-6","article-title":"Blood cell salvage and autotransfusion does not worsen oncologic outcomes following liver transplantation with incidental hepatocellular carcinoma: a propensity score-matched analysis.","volume":"28","author":"Ivanics","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"R33-20260817","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/SLA.0000000000001486","article-title":"Safety of the use of blood salvage and autotransfusion during liver transplantation for hepatocellular carcinoma.","volume":"264","author":"Han","year":"2016","journal-title":"Ann Surg"},{"key":"R34-20260817","doi-asserted-by":"crossref","first-page":"161","DOI":"10.4240\/wjgs.v8.i2.161","article-title":"Does autologous blood transfusion during liver transplantation for hepatocellular carcinoma increase risk of recurrence?","volume":"8","author":"Araujo","year":"2016","journal-title":"World J Gastroint Surg"},{"key":"R35-20260817","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.3748\/wjg.v19.i10.1625","article-title":"Effect of autotransfusion system on tumor recurrence and survival in hepatocellular carcinoma patients.","volume":"19","author":"Akbulut","year":"2013","journal-title":"World J Gastroenterol"},{"key":"R36-20260817","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/SLA.0000000000005476","article-title":"Safety of intraoperative blood salvage during liver transplantation in patients with hepatocellular carcinoma.","volume":"276","author":"Aijtink","year":"2022","journal-title":"Ann Surg"},{"key":"R37-20260817","doi-asserted-by":"crossref","first-page":"e842","DOI":"10.1097\/SLA.0000000000004866","article-title":"Blood salvage and autotransfusion with single leukoreduction does not increase the risk of tumor recurrence after liver transplantation for advanced hepatocellular carcinoma.","volume":"276","author":"Kwon","year":"2022","journal-title":"Ann Surg"},{"key":"R38-20260817","doi-asserted-by":"crossref","first-page":"4837","DOI":"10.3390\/cancers14194837","article-title":"Effect of autotransfusion in HCC surgery on survival and recurrence: a systematic review and meta-analysis.","volume":"14","author":"Murtha-Lemekhova","year":"2022","journal-title":"Cancers"},{"key":"R39-20260817","doi-asserted-by":"crossref","first-page":"261","DOI":"10.4254\/wjh.v11.i3.261","article-title":"Hepatocellular carcinoma recurrence after liver transplantation: Risk factors, screening and clinical presentation.","volume":"11","author":"Filgueria","year":"2019","journal-title":"World J Hepatol"},{"key":"R40-20260817","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1213\/ANE.0000000000005873","article-title":"A global definition of patient blood management.","volume":"135","author":"Shander","year":"2022","journal-title":"Anesth Analg"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000007998","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:00:30Z","timestamp":1787000430000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000007998"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,20]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0000000000007998","relation":{},"ISSN":["0003-2999","1526-7598"],"issn-type":[{"value":"0003-2999","type":"print"},{"value":"1526-7598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,20]]}}}